EMP_PSILO_002
Health Canada Approval
Empower Research Inc. received a No Objection Letter from Health Canada for EMP_PSILO_002: Assessing the feasibility of a psychedelic-assisted group program for depression in first responders. This marks a major milestone after many years of work and dedication.
Established Clinical Team
Our team of experienced researchers and medical professionals are dedicated to completing
this clinical trial effectively, providing a safe environment for patients within the group model.
Mitacs Grant
Empower Research Inc. was awarded a $200,000 Mitacs Accelerate grant to support the clinical research from Q4 2023 - Q4 2025, in collaboration with academic partners from around Canada.
